Skip to content

Clinical application of multidisciplinary collaborative standardized nutrition diagnosis and treatment model for head and neck cancer during the peri-radiotherapeutic period

Clinical application of multidisciplinary collaborative standardized nutrition diagnosis and treatment model for head and neck cancer during the peri-radiotherapeutic period

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068226
Enrollment
Unknown
Registered
2023-02-10
Start date
2023-02-13
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumor

Interventions

Control group:Routine nutrition education and treatment
Treatment group:Multidisciplinary collaborative standardized nutrition diagnosis and treatment model

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed head and neck cancer, mainly including nasopharyngeal carcinoma, oropharyngeal carcinoma, oral carcinoma, hypopharyngeal carcinoma, laryngeal carcinoma, etc; 2. According to the guidelines or diagnosis and treatment specifications, radiotherapy is required; 3. No serious complications can be tolerated by radiotherapy and/or chemotherapy; 4. No history of serious digestive and endocrine diseases; 5. KPS score >= 70 points; 6. Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients also have obvious chronic consumptive diseases; 2. The patient has mental illness and cannot obey the doctor's order; 3. There is obvious systemic infection; 4. The tumor has distant metastasis or other malignant tumors; 5. Serious digestive tract diseases, such as obstruction, bleeding, severe vomiting, etc; 6. Serious heart, lung, liver and kidney diseases; 7. Those who agree to participate but refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Weight and weight loss;

Secondary

MeasureTime frame
Body composition;Blood biochemistry and blood routine;PG-SGA score, daily calorie intake (DEI), daily protein intake (DPI), NRS pain score;Nutrition-inflammatory indicators;Immune function index;Metabolism-related indicators;Radiotherapy interruption rate and treatment completion rate;Objective remission rate of tumor;

Countries

China

Contacts

Public ContactZhu Yaqun

The Second Affiliated Hospital of Soochow University

szzhuyaqun@sina.com+86 130 0458 6267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026